Table 4 THE SHARE OF p16INK4a-NEGATIVE SAMPLES AMONG CERVICAL CARCINOMAS (LITERATURE DATA)
From: Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
Research group (reference) | The share (per cent) of p16INK4a-negative samples |
|---|---|
among adenocarcinomas: | |
Lu et al, 1998 (7) | 17/40 (42.5%) |
Sano et al, 1998 (8) | 4/15 (26.7%) |
Milde-Langosch et al, 2001(10) | 8/58 (13,8%) |
Klaes et al, 2001(9) | 1/7 (14.3%) |
Saqi et al, 2002 (13) | 0/2 (0%) |
Murphy et al, 2003 (14) | 0/2 (0%) |
Negri et al, 2003 (15) | 0/18 (0%) |
Agoff et al, 2003 (16) | 2/7 (28.6 %) |
Present study | 0/5 (0%) |
among squamous cell carcinomas: | |
Wong et al, 1997 (6) | 8/79 (10.1%) |
Sano et al, 1998 (8) | 1/39 (2.8%) |
Klaes et al, 2001 (9) | 1/53 (1.9%) |
Sano et al, 2002 (12) | 0/34 (0%) |
Klaes et al, 2002 (4) | 0/46 (0%) |
Saqi et al, 2002 (13) | 0/1 (0 %) |
Murphy et al, 2003 (14) | 0/8 (0%) |
Agoff et al, 2003 (16) | 4/46 (8.7%) |
Present study | 1/21 (4.8%) |